Citation Impact
Citing Papers
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
2023
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
2014
Targeting Interleukin-6 Signaling in Clinic
2019
Rheumatoid arthritis
2018 Standout
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Delivery technologies for in utero gene therapy
2020
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
2020
Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
2018
COVID-19: A promising cure for the global panic
2020 Standout
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
2020 Standout
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
2016
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
2020
Tocilizumab: A Review in Rheumatoid Arthritis
2017
Drug delivery systems for RNA therapeutics
2022
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)
2016
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis
2017
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Cytokine Storm
2020 Standout
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment
2016
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long‐Term Clinical Trial Safety Data in Rheumatoid Arthritis
2017
Works of Nina Mitchell being referenced
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
2015
OP0041 Tocilizumab (TCZ) in Combination and Monotherapy Versus Methotrexate (MTX) in MTX-Naive Patients (PTS) with Early Rheumatoid Arthritis (RA): Clinical and Radiographic Outcomes from a Randomised, Placebo-Controlled Trial
2013
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
2020